Clara Curiel, MD Clara Curiel, MD, Wins Recognition as 2018 Arizona Bioscience Researcher of the Year
September 19, 2018

The bioscience industry organization named Dr. Curiel this year’s top researcher for her pioneering work in skin cancer prevention, screening, treatment and community outreach.

UA Cancer Center multidisciplinary breast team Breast Team Asks, ‘Are You at High Risk for Breast Cancer?’ at Free Educational Presentation, Sept. 29
September 17, 2018

The UA Cancer Center’s Breast Team will educate the public about their risk for breast cancer in a presentation featuring talks about genetics, prevention and more.

Marco Padilla-Rodriguez, PhD (left) and Ghassan Mouneimne, PhD ‘Evil’ Proteins Are a Force for Good in Estrogen Receptor-Positive Breast Cancer
September 11, 2018

University of Arizona Cancer Center researchers clarify questions surrounding estrogen’s role in breast cancer, which could lead to more precise treatments for ER-positive breast cancers.

Terry A. Badger, PhD, RN $2.5M Grant to UA Nursing Professor to Ease Cancer Patients’ and Caregivers’ Psychological Distress
September 4, 2018

The four-year National Cancer Institute grant will enable Terry A. Badger, PhD, to study a precision approach to decreasing psychological distress in both cancer patients and their family caregivers during treatment.

Wen Yu “Amy” Wong, BS UA Cancer Biology Graduate Student Travels ‘ROCKy’ Road Toward a Cure for Post-Radiation Dry Mouth
August 30, 2018

The Limesand Lab at the University of Arizona is devoted to improving quality of life for head-and-neck cancer survivors, who often suffer from irreversible dry mouth.

Members of the Kuhns Lab study the "conversations" between T cells and the rest of the immune system. From left to right: Heather Parrish, PhD;  Michael Kuhns, PhD; Katrina Lichauco and Mark Lee (Kris Hanning, UAHS BioCommunications) From the Bench to the Bedside
August 10, 2018

To Develop New Immunotherapies, Collaboration Is Key

Too Much of a Good Thing: Managing Immunotherapy Side Effects
July 10, 2018

Immunotherapy can backfire when a supercharged immune system attacks healthy cells, but researchers are hopeful for the future.

Rachna Shroff, MD Pancreatic Cancer Patients with BRCA Mutation May Benefit from Targeted Drug
June 15, 2018

Rachna Shroff, MD, led a landmark study on the use of targeted drugs called PARP inhibitors in pancreatic cancer patients with BRCA mutations.

Startup Licenses UA-Invented Disruptive Biopsy Device Startup Licenses UA-Invented Disruptive Biopsy Device
June 12, 2018

The company targets accelerated diagnosis and treatment of cancer by providing optimal tissue samples for effective personalized medicine.

Daruka Mahadevan, MD, PhD, and Eric Weterings, PhD Immunotherapy: Harnessing the Power of the Immune System
June 11, 2018

Designer antibodies, like checkpoint inhibitors, have revolutionized cancer treatment.